Becton Dickinson & Co (BDX): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Becton Dickinson ( BDX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, Becton Dickinson rose 93 cents (1%) to $91.07 on average volume. Throughout the day, 1.4 million shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.1 million shares. The stock ranged in a price between $89.66-$91.07 after having opened the day at $89.98 as compared to the previous trading day's close of $90.14. Other companies within the Health Services industry that increased today were: GenMark Diagnostics ( GNMK), up 10.1%, Trius Therapeutics ( TSRX), up 7.9%, SunLink Health Systems ( SSY), up 7.4%, and Kips Bay Medical ( KIPS), up 6.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $17.38 billion and is part of the health care sector. The company has a P/E ratio of 16.3, below the S&P 500 P/E ratio of 17.7. Shares are up 15.3% year to date as of the close of trading on Tuesday. Currently there are four analysts that rate Becton Dickinson a buy, five analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Synergetics USA ( SURG), down 29.2%, Allied Healthcare Products ( AHPI), down 12.5%, AdCare Health Systems ( ADK), down 10.3%, and Navidea Biopharmaceuticals ( NAVB), down 7.3%, were all laggards within the health services industry with Brookdale Senior Living ( BKD) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

What Happened to American Society Is Happening to the Stock Market, Too: Market Recon

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways